# 🧬 MYH7 Variant Analysis & Drug Discovery Pipeline

**Advanced computational platform for precision medicine in hypertrophic cardiomyopathy (HCM)**

[![Status](https://img.shields.io/badge/Status-Active%20Development-green)](https://github.com/your-username/hcm-variant-molecule-pipeline)
[![Python](https://img.shields.io/badge/Python-3.10+-blue)](https://python.org)
[![License](https://img.shields.io/badge/License-MIT-blue)](LICENSE)

## 🎯 **Project Vision**

Transform HCM treatment through **AI-driven variant analysis** and **precision drug discovery**:
- **Clinical Impact**: Predict patient outcomes from genetic variants
- **Therapeutic Development**: Identify drug targets for specific mutations  
- **Research Excellence**: Multi-paper publication strategy
- **Commercial Potential**: Foundation for billion-dollar therapeutics company

## 📊 **Current Dataset**
- **5,890 MYH7 variants** from ClinVar
- **AlphaMissense pathogenicity scores** (AI-predicted)
- **AlphaFold structural confidence** (pLDDT)
- **Rosetta stability calculations** (ΔΔG)

## 🏗️ **Pipeline Architecture**

```
📁 Repository Structure:
├── 📓 notebooks/          # Analysis workflows
│   ├── 1_MYH7_variant_analysis.ipynb    # Core variant pipeline
│   └── 2_molecular_modeling.ipynb       # Drug discovery component
├── 🐍 src/               # Core functions & modules  
├── 📊 data/              # Raw and processed datasets
├── 📈 results/           # Figures, tables, outputs
├── 📚 docs/              # Documentation & papers
├── 🧬 MYH7_native.pdb    # AlphaFold structure
└── 📋 MYH7_variants_final_annotated.csv  # Master dataset
```

## 🚀 **Quick Start**

### 1. **Environment Setup**
```bash
# Clone repository
git clone https://github.com/your-username/hcm-variant-molecule-pipeline.git
cd hcm-variant-molecule-pipeline

# Create conda environment
conda env create -f environment.yml
conda activate hcm-pipeline
```

### 2. **Run Analysis**
```bash
# Launch Jupyter Lab
jupyter lab notebooks/1_MYH7_variant_analysis.ipynb

# Or run demo analysis
python src/demo_analysis.py
```

### 3. **Generate Results**
- Comprehensive variant analysis plots
- Top pathogenic variants identification  
- Structure-function relationships
- Drug target prioritization

## 🔬 **Research Pipeline**

### **Phase 1: Foundation Analysis** *(Current)*
- [x] Data integration (ClinVar + AlphaMissense + AlphaFold + Rosetta)
- [x] Correlation analysis (pathogenicity vs stability)
- [x] Visualization suite
- [ ] **Next**: Rosetta ΔΔG calculations for top variants

### **Phase 2: Advanced Modeling** *(Next 3 months)*
- [ ] **Desmond MD simulations** (DEShaw Research access)
- [ ] ESM-2 variant effect prediction
- [ ] AlphaFold3 structure refinement
- [ ] Population genetics integration

### **Phase 3: Drug Discovery** *(Months 4-6)*  
- [ ] Virtual compound screening
- [ ] Fragment-based drug design
- [ ] Molecular dynamics of drug-protein complexes
- [ ] ADMET prediction

## 📚 **Publication Strategy**

### **Target Journals & Timeline:**
1. **"Comprehensive MYH7 Variant Analysis"** → *Circulation: Genomic Medicine* (3 months)
2. **"Structural Mechanisms of Variant Pathogenicity"** → *Structure* (6 months)  
3. **"AI-Driven Drug Target Identification"** → *Nature Communications* (9 months)
4. **"Computational Pipeline for Variant Interpretation"** → *Bioinformatics* (12 months)

## 💡 **Key Innovations**

### **Technical Advances:**
- **Multi-modal AI integration** (AlphaMissense + AlphaFold + Rosetta)
- **Desmond MD validation** of stability predictions
- **Variant-specific drug targeting** approach
- **Clinical outcome correlation** framework

### **Clinical Applications:**
- **Precision risk stratification** for HCM patients
- **Variant-guided therapy selection**
- **Novel drug target identification**
- **Personalized treatment protocols**

## 🎯 **Commercial Potential**

### **Market Opportunity:**
- **HCM Therapeutics Market**: $1.8B by 2028
- **Recent Success**: Mavacamten ($300M+ revenue potential)
- **Unmet Need**: Variant-specific therapies

### **Monetization Strategy:**
1. **Academic Publications** → Credibility & visibility
2. **Software Licensing** → Pharma partnerships  
3. **Consulting Services** → Industry revenue
4. **Startup Formation** → Venture capital funding

## 🛠️ **Technology Stack**

### **Core Platforms:**
- **Python 3.10+** (pandas, numpy, matplotlib, seaborn)
- **BioPython** (structure analysis)
- **RDKit + DeepChem** (molecular modeling)
- **Jupyter Lab** (interactive analysis)

### **Specialized Tools:**
- **Rosetta Suite** (protein stability)
- **Desmond** (molecular dynamics) 
- **AlphaFold Database** (structures)
- **ClinVar API** (clinical variants)

### **Compute Infrastructure:**
- **Local Development** (current phase)
- **AWS/GCP** (Phase 2-3 scaling)
- **Desmond Access** (MD simulations)

## 📈 **Success Metrics**

### **Academic Impact:**
- [ ] 4+ peer-reviewed publications
- [ ] 500+ citations within 2 years
- [ ] Conference presentations at AHA/ACC

### **Clinical Translation:**
- [ ] Clinical validation study
- [ ] Electronic health record integration
- [ ] Genetic counseling tool adoption

### **Commercial Success:**  
- [ ] Industry partnerships
- [ ] Patent applications
- [ ] Startup funding rounds

## 🤝 **Contributing**

This project supports **cardiac surgery residency applications** and **drug discovery entrepreneurship**. 

### **Collaboration Opportunities:**
- Academic partnerships
- Clinical validation studies  
- Industry consulting
- Startup co-founding

## 📞 **Contact**

**Principal Investigator**: [Your Name]  
**Email**: [your.email@domain.com]  
**LinkedIn**: [your-linkedin]  
**Institution**: [Your Institution]

---

**🎯 Mission**: *Revolutionize precision medicine in cardiovascular disease through computational innovation*



